Samsara BioCapital »

Artiva Biotherapeutics shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Artiva Biotherapeutics shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.5M 292k 15.45

More positions owned by Samsara BioCapital

Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Scholar Rock Hldg Corp (SRRK)
Neurogene (NGNE)
Alumis Common Stock (ALMS)
Arcellx Common Stock (ACLX)
Lenz Therapeutics (LENZ)
Nkarta (NKTX)
Eliem Therapeutics (ELYM)
Avadel Pharmaceuticals Com Shs (AVDL)
Zymeworks Del (ZYME)
Acelyrin (SLRN)
Contineum Therapeutics Cl A (CTNM)
Jasper Therapeutics Com New (JSPR)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Capital World Investors
BlackRock
Franklin Resources
Geode Capital Management
Samsara BioCapital
Woodline Partners
Northern Trust
Citadel Advisors
Alyeska Investment Group
Charles Schwab Investment Management
Bank of New York Mellon

View all funds holding Artiva Biotherapeutics